​Join us on October 14 for an interactive discussion on how early TPP decisions can help set your program up for a clearer path from bench to bedside.

For early-stage biotech companies, a Target Product Profile (TPP) is a powerful tool for shaping development strategy, communicating the value of a program, and aligning stakeholders around what success looks like. ​

This session will explore:

• How TPPs should evolve as a program moves from early discovery toward clinical development

• What founders and development teams should be thinking about early on

• How to build a TPP, identify the key assumptions and evidence that will matter later, and anticipate potential development pitfalls before they become costly to address

---

​Due to the limited space of the venue, all registered attendees must be approved and priority goes to Biotechnology companies participating in our competitive accelerator programs.

This is an in-person event only.